Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as €46.20 ($48.63) and last traded at €45.62 ($48.02), with a volume of 254966 shares. The stock had previously closed at €45.71 ($48.12).
Fresenius Medical Care Price Performance
The company has a current ratio of 1.46, a quick ratio of 0.80 and a debt-to-equity ratio of 77.56. The stock has a market capitalization of $13.39 billion, a P/E ratio of 25.25, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The stock has a 50 day moving average of €39.38 and a 200-day moving average of €37.53.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Recommended Stories
- Five stocks we like better than Fresenius Medical Care
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- How to Master Trading Discipline: Overcome Emotional Challenges
- How to Start Investing in Real Estate
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- What is the NASDAQ Stock Exchange?
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
